Portola Pharmaceuticals: AndexXa BLA Resubmitted; Reiterating Buy
August 08, 2017 at 14:54 PM EDT
Portola issued a press release on August 3, 2017, that reported it had just resubmitted the BLA for AndexXa, which is in line with prior management guidance.